Jin Li Da Joint Novonorm particles of type 2 diabetes pancreatic β -cell function in.docVIP

 PAGE \* MERGEFORMAT 2 Jin Li Da Joint Novonorm particles of type 2 diabetes pancreatic β -cell function in Author: Gao Yu-fang LU Xiu-Xin Cao Yue-Xiang Ding Lu Feng Yue Feng-min for standard [Abstract] Objective To study the traditional Chinese medicine ‘Jin Li Da particles’ joint Novonorm treatment on islet β -cell function. Methods 300 cases of patients with type 2 diabetes, Jin Li Da particles for the treatment of joint Novonorm group, Liu Wei Di Huang Wan Long Joint Novo as the control group, assessed efficacy of treatment for 6 months. Results After treatment, FPG, 2hPG, HbA1c compared with before treatment were significantly decreased (P amp;lt;0.01); After treatment, fasting insulin (FINS), postprandial 1h, 2h (PINS1h, 2h) of water an average increase of plasma insulin, However, FINS1h, fasting C-peptide increased significantly, compared with the control group were significantly different (P amp;lt;0.05); After treatment, the HOMA-β increased significantly, HOMA-IR significantly decreased, the treatment group blood glucose compliance time, every Novonorm daily volume, the incidence of hypoglycemia were lower than the control group, there are significant differences (P amp;lt;0.05). Conclusions treatment group could delay the islet β -cell function decline. [Keywords:] Jin Li Da particles Novonorm type 2 diabetes β -cell function Abstract: ObjectiveTo discuss the efficiency of JinLiDa particle added NoVoNorm tablet on β -cell pancreatic function. Methods300 type 2 diabetes patients were divided into two groups randomly: JinLiDa particle added NoVoNorm tablet, LiuWeiDiHuang pill with NoVoNorm tablet. Then the changes of FBG, 2hPG , HbA1c, plasma insulin level, β -cell pancreatic function and insulin resistance after 6 months treatment were compared. ResultsFBG, 2HPG and HbA1C of the two groups dropped dramatically after treatment (P